Follow
Minoli Perera
Minoli Perera
Verified email at northwestern.edu
Title
Cited by
Cited by
Year
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7002021
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update
JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ...
Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017
5942017
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
MA Perera, LH Cavallari, NA Limdi, ER Gamazon, A Konkashbaev, ...
The Lancet 382 (9894), 790-796, 2013
3022013
Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor
D Yin, Y He, MA Perera, SS Hong, C Marhefka, N Stourman, L Kirkovsky, ...
Molecular pharmacology 63 (1), 211-223, 2003
1442003
The Missing Association: Sequencing‐Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans
MA Perera, E Gamazon, LH Cavallari, SR Patel, S Poindexter, RA Kittles, ...
Clinical Pharmacology & Therapeutics 89 (3), 408-415, 2011
1252011
Research directions in the clinical implementation of pharmacogenomics: an overview of US programs and projects
S Volpi, CJ Bult, RL Chisholm, PA Deverka, GS Ginsburg, HJ Jacob, ...
Clinical Pharmacology & Therapeutics 103 (5), 778-786, 2018
1122018
African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity
JP Lodolce, LE Kolodziej, L Rhee, SN Kariuki, BS Franek, NM McGreal, ...
The Journal of Immunology 184 (12), 7001-7009, 2010
1072010
Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor
Y He, D Yin, M Perera, L Kirkovsky, N Stourman, W Li, JT Dalton, ...
European journal of medicinal chemistry 37 (8), 619-634, 2002
932002
Role of pharmacogenomics in the management of traditional and novel oral anticoagulants
LH Cavallari, J Shin, MA Perera
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (12 …, 2011
802011
Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans
W Hernandez, ER Gamazon, K Aquino-Michaels, S Patel, TJ O'Brien, ...
The pharmacogenomics journal 14 (3), 223-228, 2014
792014
Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic–Americans and African–Americans
A Bress, SR Patel, MA Perera, RT Campbell, RA Kittles, LH Cavallari
Pharmacogenomics 13 (16), 1925-1935, 2012
742012
Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans
R Daneshjou, ER Gamazon, B Burkley, LH Cavallari, JA Johnson, ...
Blood, The Journal of the American Society of Hematology 124 (14), 2298-2305, 2014
732014
Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?
MA Perera, F Innocenti, MJ Ratain
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (6 …, 2008
722008
The future of warfarin pharmacogenetics in under-represented minority groups
LH Cavallari, MA Perera
Future cardiology 8 (4), 563-576, 2012
682012
Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial
MS Post, MJ Van Der Mooren, CDA Stehouwer, WM Van Baal, V Mijatovic, ...
Thrombosis and haemostasis 88 (10), 605-610, 2002
672002
Immunohistochemical localization of DARPP32 in striatal projection neurons and striatal interneurons in pigeons
A Reiner, M Perera, R Paullus, L Medina
Journal of chemical neuroanatomy 16 (1), 17-33, 1998
641998
Novel genetic predictors of venous thromboembolism risk in African Americans
W Hernandez, ER Gamazon, E Smithberger, TJ O’Brien, AF Harralson, ...
Blood, The Journal of the American Society of Hematology 127 (15), 1923-1929, 2016
552016
The missing linkage: what pharmacogenetic associations are left to find in CYP3A?
MA Perera
Expert opinion on drug metabolism & toxicology 6 (1), 17-28, 2010
542010
Genetic factors influencing warfarin dose in Black‐African patients: a systematic review and meta‐analysis
IG Asiimwe, EJ Zhang, R Osanlou, A Krause, C Dillon, G Suarez‐Kurtz, ...
Clinical Pharmacology & Therapeutics 107 (6), 1420-1433, 2020
532020
Association of the GGCX (CAA) 16/17 repeat polymorphism with higher warfarin dose requirements in African Americans
LH Cavallari, M Perera, M Wadelius, P Deloukas, G Taube, SR Patel, ...
Pharmacogenetics and genomics 22 (2), 152-158, 2012
522012
The system can't perform the operation now. Try again later.
Articles 1–20